Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-07-29 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is an official communication ('Informazione Regolamentata') dated July 29, 2021, regarding Bioera S.p.A. The subject ('Oggetto') is 'Richiesta di conversione Warrant A' (Request for conversion of Warrant A). The text details the receipt of a request from Negma Group Limited to convert 1,063,830 Warrant A into new ordinary shares, specifying the conversion price and the resulting change in the total number of outstanding shares. This action directly relates to changes in the company's capital structure and financing instruments (warrants conversion leading to new share issuance). This fits best under 'Capital/Financing Update' (CAP), as it is a specific event detailing the exercise of warrants which alters the capital base, rather than a general announcement of a financing round (CAP) or a simple share repurchase (POS). Since it is a specific corporate action impacting capital, CAP is the most precise fit.
2021-07-29 Italian
Bioera S.p.A. - Informativa al mercato ex art. 114, co. 5, D.lgs. n. 58/98 (“TUF”) - periodo di riferimento: 30.06.2021
Regulatory Filings Classification · 1% confidence The document is an official communication from Bioera S.p.A. titled "Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ('TUF') periodo di riferimento: 30.06.2021". This regulation (Article 114, paragraph 5 of the TUF - Testo Unico della Finanza) mandates the disclosure of specific financial information (like Net Financial Position) by listed companies to the market, typically when requested by CONSOB or on specific reporting dates, but it is not the full periodic financial report (like 10-K or IR). The content focuses on the Net Financial Position (Posizione Finanziaria Netta) as of June 30, 2021, comparing it to previous periods. This type of mandatory, specific financial disclosure, often triggered by regulatory requests or specific interim dates outside the standard quarterly/annual cycle, fits best under the category for comprehensive interim reports or specific regulatory disclosures. Since it provides detailed financial data (tables showing cash, debt, etc.) for an interim period (30.06.2021) but is explicitly mandated by a specific article of Italian financial law (TUF) rather than being a standard quarterly report (IR), it is classified as an Interim/Quarterly Report (IR), as it contains detailed financial figures for a period shorter than a year. It is not a mere announcement (RPA) because the core content (the tables and analysis) is present, despite the initial note saying 'Vedi allegato' (See attachment), which is common even in substantive filings.
2021-07-28 Italian
Bioera S.p.A. - Comunicazione di variazione del capitale sociale
Share Issue/Capital Change Classification · 1% confidence The document is titled "Comunicazione di variazione del capitale sociale" (Communication of change in share capital) and details the new composition of the share capital following the conversion of warrants. It explicitly states the change in the number of shares and provides an updated shareholder structure table. This directly relates to changes in the company's capital structure. According to the definitions, 'Capital/Financing Update' (CAP) covers updates on company fundraising, financing activities, or capital structure changes. Although it is a formal communication, the core subject matter is the capital structure change, making CAP the most precise fit over a general 'RNS' or 'SHA' (which is more for new issues/splits, though this is a result of conversion). Given the detailed nature of the capital change announcement, CAP is appropriate.
2021-07-21 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from Bioera S.p.A., identified by the header 'Informazione Regolamentata n. 0771-60-2021' and the subject 'Richiesta di conversione Warrant A'. It details a specific corporate action: the conversion of warrants into new ordinary shares and the issuance of new Warrant B securities. This action directly impacts the company's capital structure and share count. This falls under the category of financing activities or capital structure changes. While it relates to warrants (which can sometimes be financing), the core event is a change in capital structure resulting from the exercise/conversion. The most fitting category among the provided options is 'Capital/Financing Update' (CAP), as it describes the issuance of new shares resulting from a financing instrument conversion. It is not a general earnings release (ER), an interim report (IR), or a simple dividend notice (DIV). Since it is a specific announcement about capital structure change via warrant conversion, CAP is the best fit.
2021-07-20 Italian
Bioera S.p.A. - Deposito verbale assemblea ordinaria degli azionisti del 30 giugno 2021
Report Publication Announcement Classification · 1% confidence The document is a formal announcement (Informazione Regolamentata) dated July 15, 2021, regarding the filing of the minutes ('verbale') of the Ordinary Shareholders' Meeting held on June 30, 2021. The key phrase is 'Deposito verbale assemblea ordinaria degli azionisti' (Filing of the minutes of the ordinary shareholders' meeting). Since this document is an announcement stating that the minutes are available to the public (at the registered office, on the website, and via eMarket Storage), and the document itself is short (3083 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the minutes document itself (which would likely be classified under AGM-R if it were the presentation/material, or potentially RNS if it were a generic regulatory filing). However, given the specific nature of announcing the availability of meeting minutes, RPA is the most precise fit among the options for an announcement about a published document.
2021-07-15 Italian
Verbale assemblea ordinaria degli azionisti del 30 giugno 2021
AGM Information Classification · 1% confidence The document is titled "VERBALE DI ASSEMBLEA ORDINARIA" (Minutes of the Ordinary Shareholders' Meeting) and details the proceedings, attendees, quorum checks, and resolutions passed during a meeting held on June 30, 2021. The agenda items explicitly include the approval of the financial statements for the year ended December 31, 2020, and remuneration policy votes. This content is characteristic of the formal record of an Annual General Meeting (AGM). Although it discusses the approval of the annual financial statements (which might suggest a 10-K or AR), the primary nature of the document is the minutes of the meeting itself, which aligns best with AGM-R (AGM Information/Minutes).
2021-07-15 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.